AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024

Currently Viewing Abstracts from 2009

Title
160-week Interim Results from an Open-Label Extension Trial of Olanzapine Long-Acting Injection
A Characterization of Polypharmacy in an Inpatient Bipolar Population
A Comparison of Diabetic Adults and Non-Diabetic Adults with Respect to Progression of Dementia in the Texas Medicaid System
A Drug Use Evaluation of Dexmedetomidine as a Adjunctive Therapy in Acute Alcohol Withdrawal
A Pharmacogenetic Consultation Service at a Private Psychiatric Facility
A Population Pharmacokinetic Analysis for Aripiprazole in Children and Adolescents Ages 10-17
A randomized, double-blind, placebo-controlled, dose-response efficacy/safety study of paliperidone palmitate in adults with schizophrenia
A RETROSPECTIVE EVALUATION OF TOTAL DAILY DOSING OF ANTIPSYCHOTICS IN A PRIVATE PSYCHIATRIC HOSPITAL
ADD-ON AMANTADINE THERAPY TO INDUCE WEIGHT LOSS IN PSYCHIATRIC PATIENTS ALREADY RECEIVING TOPIRAMATE THERAPY
Alcohol effects on drug release from Venlafaxine Extended Release Tablets
An 8-Week Open-Label Study of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder and Comorbid Social Anxiety Disorder
An Analysis of CYP450 Genotype and Patients' Perceived Response and Tolerance to their Antidepressants
An Open-Label Trial of Topiramate for the Management of Nightmares related to Post-Traumatic Stress Disorder- Extension Study
ANALYSIS OF ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN A COMMERCIAL POPULATION
Antipsychotic prescribing patterns following implementation of mental health quality edits in a Medicaid program
Aripiprazole for the Treatment of Adolescent Tourette’s Syndrome: A Case Report
Assessing medication adherence as a risk factor for hospitalization in a community psychiatric hospital
ASSESSMENT OF ANTIPSYCHOTIC POLYPHARMACY IN INPATIENTS WITH SCHIZOPHRENIC DISORDERS ON LONG-ACTING INJECTABLE AGENTS
Assessment of Monitoring for Glucose and Lipid Dysregulation in Adult Medi-Cal Patients Newly Started on Antipsychotics
Association Between Cytochrome P450 2D6 and 2C19 Phenotype and Occurrence of Adverse Drug Reactions in Pediatric Psychiatry Inpatients
Association between GRM3 and GRIN2B gene variants and symptoms in treatment refractory schizophrenia
Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder and Comorbid Social Anxiety Disorder
Can point-of-care testing by pharmacists improve early detection and management of metabolic syndrome due to second generation antipsychotic agents?
Cardiometabolic Impact of Atypical Antipsychotics: 10 Years Later
Caregivers: An Understudied Area
CHARACTERISTICS OF ORAL ANTIPSYCHOTIC POLY-PHARMACY WITHIN A COMMERCIAL PHARMACY BENFITS MANAGER
Clozapine-Induced Myocarditis: Two Case Reports
Comparison of a diazepam loading dose strategy versus a fixed dose regimen with lorazepam in the treatment of alcohol withdrawal syndrome among general medical inpatients
Comparison of Atypical Antipsychotic Drugs Using Time to Discontinuation as a Proxy for Effectiveness
COMPARISON OF PROPOFOL VERSUS METHOHEXITAL AS ANESTHETIC AGENTS FOR ELECTROCONVULSIVE THERAPY IN TREATMENT OF DEPRESSION
Comparison of Psychiatric Inpatients Treated with Clozapine and Olanzapine: Post-Smoking Cessation
Comparison of the frequency of methyltetrahydrofolate reductase (MTHFR) C677T in depressed patients treated by a primary care physician versus those treated by a psychiatrist
Comparison of Two Annual Surveys: Understanding National Alliance on Mental Illness (NAMI) Members’ Perception of Psychiatric Pharmacists
Comparisons of Symptom Improvement and Tolerability for Duloxetine-treated Male and Female Patients with Major Depressive Disorder (MDD)
COMT Variants Associated with Duloxetine Response: A Candidate Gene Association Analysis of a Randomized Clinical Treatment Trial for Major Depression
Decreasing Deliberate Ingestion of prescribed substances in patients with a history of substance abuse
Demonstrating Proof of Principle in Alzheimer’s Disease (AD): The Role of CSF ‘Dynabridging’ Studies
Depression and Diabetes: A Retrospective, Cross-Sectional, Chart Review Study.
Development of a Pharmacist Managed Warfarin Protocol in a Psychiatric Hospital
DEVELOPMENT OF A PHARMACIST RUN PSYCHIATRIC MEDICATION MANAGEMENT SERVICE AT A SAFETY NET CLINIC
Dextromethorphan and chlorpheniramine overdose during first-trimester pregnancy in an adolescent
Discharge Follow Up with a Pharmacist: Discharge Education, Medication Reconciliation, and an Outpatient Follow Up Service for Patients with Psychiatric Illness Discharged to an Adult Day Treatment Program
Do Early Changes in Triglycerides Predict Later Changes During Olanzapine Treatment?
Does Recovery from Substance Use among Patients with Bipolar Disorder Improve Medication Adherence and Drug Attitudes
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
EFFECTIVENESS OF HEMOGLOBIN A1c MONITORING IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ATYPICAL ANTIPSYCHOTICS
EFFECTS OF A PHARMACIST INTERVENTION ON MONITORING METABOLIC EFFECTS OF SECOND GENERATION ANTIPSYCHOTICS
Effects of Benzodiazepine Use on Treatment Outcomes of Multidisciplinary Pain Rehabilitation
EFFECTS OF OMEPRAZOLE ON THE PHARMACOKINETIC PROFILES OF LISDEXAMFETAMINE DIMESYLATE AND MIXED AMPHETAMINE SALTS EXTENDED RELEASE IN ADULTS
Ephedrine Withdrawal Causes Severe Psychiatric Symptoms: A Case Report
EVALUATING THE UTILITY OF A PHARMACY PRACTICE RESIDENT AS A LIAISON FOR PSYCHIATRIC SERVICES IN A COMMUNITY HOSPITAL
Evaluation of a buprenorphine/naloxone clinic for office-based treatment of opioid dependence
Evaluation of Adherence to Recommended Mental Health Care Provided to Operation Enduring Freedom/Operation Iraqi Freedom Veterans with a Positive Screen for Post Traumatic Stress Disorder
Evaluation of Adherence to the Metabolic Monitoring Protocol on mental health units at an urban tertiary teaching hospital
EVALUATION OF ANTIPSYCHOTIC POLYPHARMACY IN A VETERAN POPULATION
Evaluation of medication errors in the inpatient behavioral health unit
Evaluation of the Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
Evaluation of the Impact of Potential Quality Edits on Antipsychotic Use in Pediatrics
Evaluation of the use of classroom reflections and biographical readings on pharmacy students' learning about mental illness
Evaluation of Treatment and Clinical Outcomes of Schizoaffective Disorder in an Inpatient Psychiatric Facility
Extended-Release (ER) Memantine Capsule (28 mg, Once Daily): A Multiple-Dose, Open-Label Study Evaluating Steady-State Pharmacokinetics in Healthy Volunteers
Extended-release memantine (28 mg, once daily) improves verbal fluency and behavior in patients with moderate to severe Alzheimer’s disease: results of a multinational, double-blind, placebo-controlled trial
Feasibility of Administering a Pharmacist Consultation Service Targeting Inpatients with Bipolar Disorder, Most Recent Episode Depressed
FIBROMYALGIA AND MAJOR DEPRESSIVE DISORDER: ASSESSMENT OF PAIN AND DEPRESSION CONTROL IN AN OUTPATIENT ADULT PSYCHIATRY CLINIC
Going Paperless with Web-based Medication Variance Reporting System
GUANFACINE EXTENDED RELEASE FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: IMPACT OF TREATMENT DURATION ON SEDATION-RELATED ADVERSE EVENTS
High Utilizers of Inpatient State Hospital Services
HOSPITALIZATION RATES AMONG INDIVIDUALS WITH BIPOLAR DISORDER INITIATING THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE
Hypomania Secondary to a Change in Altitude in an Adolescent Male
Identification of Symptoms that Predict Antipsychotic Response in Schizophrenia
IMPACT OF PRESCRIBING FEEDBACK ON ANTIPSYCHOTIC POLYPHARMACY
Implementation of a smoke-free policy at an university hospital inpatient psychiatric unit
INCIDENCE OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ANTIDEPRESSANTS IN A VETERAN POPULATION
Initiation dosing of deltoid intramuscular paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on modeling and simulation
LISDEXAMFETAMINE DIMESYLATE DEMONSTRATED CONSISTENT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) SYMPTOM CONTROL THROUGHOUT THE DAY UP TO 13 HOURS IN A LABORATORY SCHOOL STUDY IN CHILDREN
LONG-TERM EFFICACY AND SAFETY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Long-term efficacy, safety and tolerability of paliperidone palmitate in patients with schizophrenia
Low Potential for Pharmacokinetic Drug-Drug Interactions With Milnacipran in Fibromyalgia Management
Maintenance dosing of once-monthly (4-weekly) paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on population based simulations
MEDICATION SATISFACTION IN SUBJECTS WITH SCHIZOPHRENIA TREATED WITH PALIPERIDONE ER AFTER SUBOPTIMAL RESPONSE TO ORAL RISPERIDONE
Medication Use Evaluation of paliperidone in Improving Patient outcomes in an Inpatient Psychiatric Facility
Memantine’s effect on CAPS scores in an Iraq War combat veteran’s PTSD
Metabolic Monitoring of Patients Receiving Clozapine
NALTREXONE USE AND HEALTHCARE UTILIZATION IN A VETERAN POPULATION
Non-adherence to Pharmacotherapy as a Potential Risk Factor for Relapse to Substance Use Disorder in Dual Diagnosis Patients
Olanzapine Long-acting Injection: A 24-Week, Randomized, Double-blind Trial of Maintenance Treatment in Patients with Schizophrenia
Open-label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
OPEN-LABEL COADMINISTRATION OF GUANFACINE EXTENDED RELEASE AND STIMULANTS IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
OXCARBAZEPINE-INDUCED THROMBOCYTOPENIA AND NEUTROPENIA: A CASE REPORT
Paliperidone Overdose: A Case Report
Patient Experience and Satisfaction With Lisdexamfetamine Dimesylate in Adults With ADHD Who Were Previously Treated With Mixed Amphetamine Salts Extended Release
Patients’, Physicians’ and Pharmacists’ Evaluation of Depression Patient’s Preference for Tablets Versus Capsules
Pharmacy Sponsored Psycho-education Process Group for Recovery of PTSD
PHARMACY STUDENTS’ ATTITUDES TOWARD MENTAL ILLNESS AT THE BEGINNING AND END OF THE PROFESSIONAL CURRICULUM
Physicians' Self-reported Antidepressant Monitoring for Children and Adolescents with Major Depressive Disorder
Physicians’ and Pharmacists’ Perception of the Value of Specific Tactics Aimed to Reduce Nonadherence in Patients with Major Depressive Disorder (MDD)
POST-ICTAL PSYCHOSIS SUCCESSFULLY TREATED WITH QUETIAPINE: A CASE REPORT
Post-Injection Delirium/Sedation Syndrome Observed with Olanzapine Long-Acting Injection
PREVALANCE OF CARDIOVASCULAR RISK FACTORS AND METABOLIC SYNDROME IN AN INPATIENT MENTAL HEALTH FACILITY
Psychiatric Pharmacist in a Overdose Prevention Education Team
Psychiatric Pharmacy Practice in a Homeless Shelter's Mental Health Clinic
Relationship between clozapine plasma concentrations and rehospitalization
Relationship Between The Brain Derived Neurotrophic Factor (BDNF) Val66Met Variant And Metabolic Complications Seen With Antipsychotic Use In Schizophrenia Subjects.
Relationships between Ethnicities and Treatment Outcomes in Schizophrenia Patients
Results of point-of-care glucose testing and basic metabolic screening in outpatients on antipsychotic agents
Retrospective analysis of implementing a tobacco-free campus at a behavioral health center
Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia
SAFETY AND EFFICACY OF VARENICLINE IN HOSPITALIZED PSYCHIATRIC PATIENTS
Safety and Tolerability of Duloxetine in the Treatment of Patients with Fibromyalgia: Analysis of 5 Studies
Safety Survey of Varenicline in a US Veteran Population
SUBLINGUAL BUPRENORPHINE / NALOXONE USE IN THE PAIN MANAGEMENT CLINIC
Switching To Duloxetine From SSRI Non- And Partial-Responders: Does The Type Of SSRI Prior To Switch Influence Outcomes?
The Diagnosis of ADHD (Attention Deficit Hyperactivity Disorder) and Stimulant Medication Utilization Patterns among Students in a University School of Pharmacy Setting
The Effect of P-Glycoprotein Inhibition on Desloratadine in the CNS
The Efficacy of Desvenlafaxine 50 mg/d for Improving Anxiety Symptoms in Patients With Major Depressive Disorder: A Pooled Analysis
THE EVALUATION OF TREATMENT CONTINUATION RATES OF ARIPIPRAZOLE AND QUETIAPINE IN BIPOLAR DISORDER
The Impact of Discharge Planning on Medication Adherence in Patients Receiving Risperidone Long-Acting Injectable
The Pattern of Cannabis Use and Withdrawal Symptoms in People with Schizophrenia
THE PERSPECTIVE OF THE INDIVIDUAL WITH SCHIZOPHRENIA REGARDING PHARMACEUTICAL CARE.
The Relationship of Brain Weight to Body Mass Index (BMI) Upon Autopsy in People with Severe Mental Illness
The Utilization of As Needed Anti-Anxiety Medication Prior to and Following the Implementation of a Smoke-Free Behavioral Health Campus
To use or not to use: antipsychotics in the elderly
Treatment Costs and Health Care Utilization for Schizophrenic Patients in the Medi-Cal System
TREATMENT EFFICACY OF ATYPCAL ANTIPSYCHOTIC-INDUCED HYPERTRIGLYCERIDEMIA AMONG VETERANS AFFAIRS PSYCHIATRIC PATIENTS
Treatment of Ephedrine Dependence with Low-Dose Aripiprazole
Use of Cooperative Teaching to Deliver Psychiatry/Neurology Modules in a Pharmacotherapy Course Series
Utilization of Cholinesterase Inhibitors and Memantine in the Reduction of Antipsychotic Prescribing for Dementia Related Behavior
Venous thromboembolism rates among patients treated with antipsychotics and selective serotonin inhibitors